PNEUMOCOCCAL INFECTION
Clinical trials for PNEUMOCOCCAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTION trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine V118C aims to shield kids from pneumococcal disease
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial is testing a new vaccine called V118C to prevent pneumococcal disease, which can cause serious lung and other infections. About 210 toddlers and infants will receive either V118C or an existing vaccine to compare safety and immune response. The study is cur…
Matched conditions: PNEUMOCOCCAL INFECTION
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:08 UTC
-
Why vaccines may fail in older adults: new study investigates immune cell role
Knowledge-focused Recruiting nowThis study looks at how a type of immune cell called neutrophils affects the body's response to the pneumococcal vaccine in young (21-40) and older (65+) adults. Researchers will measure how well neutrophils kill pneumonia bacteria after vaccination. The goal is to understand why…
Matched conditions: PNEUMOCOCCAL INFECTION
Phase: PHASE4 • Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC